title: Immune responses following simian/human immunodeficiency virus (SHIV) challenge of rhesus macaques after human immunodeficiency virus (HIV)-1 third variable domain (V3) loop-based genetic immunization.
abstract: Following DNA immunization of rhesus macaques with a plasmid encoding the human immunodeficiency virus (HIV)-1 third variable domain (V3) loop, presented by pseudo-viral envelope particles of hepatitis B virus, specific immune responses were induced. The primates were then inoculated with a chimeric simian/human immunodeficiency virus (SHIV). All the animals were infected, but the V3-specific immunization provided a relative attenuation of the acute phase of infection in the absence of neutralizing antibody. In all animals, SHIV-specific cytotoxic T-lymphocyte precursors (CTLp) were detected early in peripheral blood and lymph nodes. The viremia peak correlated significantly with the decrease in CD4+ T cells and with a transient increase in the percentage of natural killer cells. The infection induced an oligoclonalization of the CD8+ T-cell variable beta chain repertoire in the blood. Surprisingly, HIV envelope-specific CTLp generated by genetic immunization may be governed by distinct circulation rules compared to SHIV-specific CTLp induced by infection.
authors.affiliation: Laboratoire d'Immunopathologie Virale, URA CNRS 1930, Institut Pasteur, Paris, France. riviere@pasteur.fr
authors.forename: S
authors.initials: S
authors.lastname: Le Borgne
authors.forename: R
authors.initials: R
authors.lastname: Le Grand
authors.forename: M L
authors.initials: ML
authors.lastname: Michel
authors.forename: B
authors.initials: B
authors.lastname: Vaslin
authors.forename: B
authors.initials: B
authors.lastname: Boson
authors.forename: G
authors.initials: G
authors.lastname: Janvier
authors.forename: A M
authors.initials: AM
authors.lastname: Aubertin
authors.forename: D
authors.initials: D
authors.lastname: Dormont
authors.forename: Y
authors.initials: Y
authors.lastname: Rivière
mesh_terms: D016915:AIDS Vaccines / Q000276:immunology*; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D015153:Blotting, Western; D018791:CD4 Lymphocyte Count; D018414:CD8-Positive T-Lymphocytes / Q000502:physiology; D004797:Enzyme-Linked Immunosorbent Assay; D015699:HIV Envelope Protein gp120 / Q000235:genetics / Q000276:immunology*; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D008253:Macaca mulatta / Q000276:immunology*; D010446:Peptide Fragments / Q000235:genetics / Q000276:immunology*; D010641:Phenotype; D016133:Polymerase Chain Reaction; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000517:prevention & control*; D013997:Time Factors; D019444:Vaccines, DNA / Q000276:immunology; D019562:Viral Load
chemical_list: D016915:AIDS Vaccines; D000914:Antibodies, Viral; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments; D019444:Vaccines, DNA